The group also investigated the miRNA-mRNA pathway using prostate cancer cell lines and demonstrated that miR-96 could bind FOXO1 mRNA, which is a tumor suppressor, resulting in a reduction of FOXO1 protein thus, increasing cell growth and proliferation [81]. This evidence concerns the gene FOXO1 and prostate carcinoma.